{
    "id": 8879,
    "fullName": "RAF1 P261T",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "RAF1 P261T lies within the CR2 domain of the Raf1 protein (PMID: 17603482). P261T results in increased Raf kinase activity, downstream Mek and Erk phosphorylation and has been demonstrated to occur as a resistance mutation (PMID: 23737487).",
            "references": [
                {
                    "id": 494,
                    "pubMedId": 17603482,
                    "title": "Germline gain-of-function mutations in RAF1 cause Noonan syndrome.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17603482"
                },
                {
                    "id": 3186,
                    "pubMedId": 23737487,
                    "title": "C-RAF mutations confer resistance to RAF inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23737487"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5894,
        "geneSymbol": "RAF1",
        "terms": [
            "RAF1",
            "c-Raf",
            "CMD1NN",
            "CRAF",
            "NS5",
            "Raf-1"
        ]
    },
    "variant": "P261T",
    "createDate": "07/09/2015",
    "updateDate": "07/22/2019",
    "referenceTranscriptCoordinates": {
        "id": 161825,
        "transcript": "NM_002880",
        "gDna": "chr3:g.12604189G>T",
        "cDna": "c.781C>A",
        "protein": "p.P261T",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2514,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, expression of RAF1 P261T conferred resistance to Zelboraf (vemurafenib) in human melanoma cells expressing BRAF V600E in culture (PMID: 23737487).",
            "molecularProfile": {
                "id": 8791,
                "profileName": "BRAF V600E RAF1 P261T"
            },
            "therapy": {
                "id": 342,
                "therapyName": "Vemurafenib",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3186,
                    "pubMedId": 23737487,
                    "title": "C-RAF mutations confer resistance to RAF inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23737487"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2515,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, expression of RAF1 P261T conferred resistance to PLX4720 in human melanoma cells expressing BRAF V600E in culture (PMID: 23737487).",
            "molecularProfile": {
                "id": 8791,
                "profileName": "BRAF V600E RAF1 P261T"
            },
            "therapy": {
                "id": 1060,
                "therapyName": "PLX4720",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3186,
                    "pubMedId": 23737487,
                    "title": "C-RAF mutations confer resistance to RAF inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23737487"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 8773,
            "profileName": "RAF1 P261T",
            "profileTreatmentApproaches": [
                {
                    "id": 6003,
                    "name": "Trametinib",
                    "profileName": "RAF1 P261T"
                },
                {
                    "id": 5945,
                    "name": "RAF Inhibitor (Pan)",
                    "profileName": "RAF1 P261T"
                }
            ]
        },
        {
            "id": 8791,
            "profileName": "BRAF V600E RAF1 P261T",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 161825,
            "transcript": "NM_002880",
            "gDna": "chr3:g.12604189G>T",
            "cDna": "c.781C>A",
            "protein": "p.P261T",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 161827,
            "transcript": "XM_005265355",
            "gDna": "chr3:g.12604189G>T",
            "cDna": "c.781C>A",
            "protein": "p.P261T",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 161826,
            "transcript": "XM_011533974",
            "gDna": "chr3:g.12604189G>T",
            "cDna": "c.781C>A",
            "protein": "p.P261T",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}